During the past decade, North Coast Cancer Care - Clyde conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 55 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Coast Cancer Care - Clyde" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Eastern Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Coast Cancer Care - Clyde" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "North Coast Cancer Care - Clyde" are "Breast Cancer" (8 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (5 trials), "Recurrent Breast Carcinoma" (4 trials), "Clear Cell Renal Cell Carcinoma" (3 trials) and "Leukemia" (3 trials). Many other conditions were trialed in "North Coast Cancer Care - Clyde" in a lesser frequency.

Most popular intervention types in "North Coast Cancer Care - Clyde" are "Drug" (59 trials), "Other" (39 trials), "Biological" (32 trials), "Procedure" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (24 trials), "Bevacizumab" (13 trials), "Paclitaxel" (9 trials), "Quality-of-Life Assessment" (8 trials) and "placebo" (8 trials). Other intervention names were less common.

The vast majority of trials in "North Coast Cancer Care - Clyde" are 49 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "North Coast Cancer Care - Clyde". undefined are not yet recruiting, undefined are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in North Coast Cancer Care - Clyde, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in North Coast Cancer Care - Clyde, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".